CSIMarket
 
Masimo Corp  (MASI)
Other Ticker:  
 
 
Price: $132.6800 $0.48 0.363%
Day's High: $133.17 Week Perf: 2.62 %
Day's Low: $ 129.43 30 Day Perf: 0.03 %
Volume (M): 1,053 52 Wk High: $ 198.00
Volume (M$): $ 139,686 52 Wk Avg: $129.57
Open: $131.09 52 Wk Low: $75.22



 Market Capitalization (Millions $) 7,161
 Shares Outstanding (Millions) 54
 Employees 8,815
 Revenues (TTM) (Millions $) 2,048
 Net Income (TTM) (Millions $) 82
 Cash Flow (TTM) (Millions $) -41
 Capital Exp. (TTM) (Millions $) 88

Masimo Corp
Masimo Corporation is a publicly traded medical technology company that was founded in 1989 by Joe Kiani. Its headquarters is located in Irvine, California, and it is considered one of the leading innovators in the healthcare industry. Masimo has a global presence and operates in over 130 countries.

Masimo's primary focus is on developing and manufacturing innovative solutions to improve patient outcomes and reduce healthcare costs. The company produces a range of products that include patient monitoring systems, pulse oximeters, sensors, and other medical devices. Masimo's products are used in hospitals, clinics, home healthcare settings, emergency medical services, military and veterinary settings.

One of Masimo's most famous inventions is the Signal Extraction Technology (SET), which is a patented technology that revolutionized pulse oximetry. Pulse oximetry is a non-invasive method of measuring a person's oxygen saturation levels, and SET technology significantly improves the accuracy and reliability of this measurement, preventing misdiagnosis and unnecessary interventions.

Masimo has received several prestigious awards and recognition for its innovative products and services. In 2021, Masimo was ranked as one of the World's Most Innovative Companies by Forbes, an accolade that the company has received multiple times in the past.

The company's growth has been fueled by its continuous investments in research and development. Masimo has a robust pipeline of new products and services in development that are designed to improve patient outcomes and quality of care while reducing healthcare delivery costs.

Furthermore, Masimo is also committed to sustainability and social responsibility. The company's sustainability program includes initiatives to reduce its carbon footprint, increase recycling, and minimize waste. It also supports various charitable organizations globally, providing life-saving medical equipment, supplies, and medicine to people in need.

Overall, Masimo Corporation is considered a trailblazer in the medical technology industry, with an exceptional track record of developing and delivering innovative solutions that revolutionize the healthcare industry. Its commitment to sustainability and social responsibility makes it a standout business in its field.


   Company Address: 52 Discovery Irvine, 92618 CA
   Company Phone Number: 297-7000   Stock Exchange / Ticker: NASDAQ MASI
   


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
VZIO        0.72% 
• View Complete Report
   



Masimo Corp

Masimo Corporation Faces Revenue Decline and Earnings Drop in Fiscal Fourth Quarter of 2023



In the fiscal fourth quarter of 2023, Masimo Corporation (NASDAQ: MASI), a prominent player in the Medical Equipment & Supplies sector, experienced a decline in revenue and bottom-line. The company reported a decrease of 18.55% in income, resulting in earnings per share (EPS) falling to $0.63. Revenue also took a hit, dropping by 11.064% year on year, with figures amounting to $548.70 million compared to $616.96 million in the same period of the previous year.
Revenue Performance:
While Masimo Corporation faced a decrease in revenue, the Medical Equipment & Supplies sector as a whole witnessed a rise in the fourth quarter of 2023. In comparison to previous periods, the company demonstrated an impressive 14.599% revenue growth from $478.8 million and a 216.82% growth in EPS from $0.20 per share.

Management Changes

Masimo Welcomes Bob Chapek, Former Disney CEO, to Its Board of Directors: A Promising Collaboration in the Healthcare Industry

Published Tue, Jan 16 2024 9:05 PM UTC


In an exciting development, Masimo Corporation (NASDAQ: MASI) has recently announced the appointment of Bob Chapek to its Board of Directors. Chapek is renowned for his successful tenure as the Chief Executive Officer of The Walt Disney Company from February 2020 to November 2022. During his leadership, Chapek effectively steered Disney through the challenging times bro...

Masimo Corp

Masimo Corp Reports Significant Decline in Q3 2023 Earnings Amidst Challenging Market Conditions

The stock market has continued to be a source of uncertainty and volatility in recent times, with many investors nervously watching their portfolios. However, amidst the turbulence, there are still opportunities to be found. One such opportunity lies in Masimo Corp, a company that has experienced some setbacks in the most recent fiscal period but remains a promising investment prospect.
In the last fiscal period, Masimo Corp saw a decline in net profit per share of -71.43%, dropping from $0.70 per share to $0.20 per share compared to the previous year. Similarly, income faded by -31.03% from $0.29 per share in the previous reporting season. These figures may cause concern for some investors, but it's important to consider the wider context.

Masimo Corp

Masimo Corp Reports Impressive Revenue Surge of 49.618% in Q2 2023, Despite Declining Earnings

Masimo Corp, a leading Medical Equipment & Supplies company, has reported its earnings for the most recent fiscal period. The company announced earnings per share (EPS) of $0.29 and revenue of $565.00 million. This represents a significant decline in earnings compared to the same three months a year before when Masimo Corp earned EPS of $0.81.
However, despite the decline in earnings, Masimo Corp saw its revenue rise by an impressive 49.618% in the same period. This growth in revenue far outpaces the rest of the Medical Equipment & Supplies sector, which reported a mere 4.51% top-line growth during the same period.

Masimo Corp

Masimo Corp's Earnings Deteriorate, but Stock Market Remains Bullish on Future Performance

Despite Masimo Corp's lower than average return on investment in the first quarter of 2023, the stock market remains optimistic about this prominent healthcare company's future performance.
Although the ROI decreased compared to the previous reporting period, and Masimo Corp ranked lower among its competitors, the company's leadership has taken proactive measures to improve its financial outlook. By prioritizing sales in the first quarter of 2023, Masimo Corp was able to achieve a modest revenue elevation, which should set the stage for future growth opportunities.






 

Masimo's Segments
 
 
• View Complete Report
  Company Estimates  
  Revenue Outlook
Masimo does not provide revenue guidance.

Earnings Outlook
Masimo Corp does not provide earnings estimates.

 
Geographic Revenue Dispersion




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com